Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Sanofi Ousts CEO Viehbacher
by Lisa M. Jarvis
November 3, 2014
| A version of this story appeared in
Volume 92, Issue 44
The board of the French drug giant Sanofi has fired CEO Christopher A. Viehbacher. The board made clear its problems lay not with Viehbacher’s strategy but with disagreements about management style. Viehbacher took the helm at Sanofi in 2008 and proceeded to turn around a business facing patent losses on top-selling products. But after that transformation, Viehbacher’s management style “was not adequate,” Serge Weinberg, chairman of Sanofi’s board, told investors last week. Weinberg, who will serve as interim CEO, says the company is looking outside its walls for a new CEO.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter